Prognos, formerly known as Medivo, is a healthcare AI company focused on predicting disease. The Company aggregates, normalizes and provides clinical interpretation of clinical diagnostics data at scale, using HIPAA compliant infrastructure. The Company's AI platform enables early prediction of disease onset, therapy need, clinical trial opportunity, care gaps, and risk, using clinical algorithms across a range of conditions.
|HQ||New York, US||Map|
|Employees (est.) (May 2019)||87||(+3%)|
Prognos total Funding
Prognos latest funding size
Time since last funding
|a year ago|
|Safeguard Scientifics, MentorTech Ventures, Merck Global Health Innovation Fund, Cigna, Hikma Ventures, Hermed Capital, Tom Nicholson, Maywic Select Invsestments, Guardian Life|
|Acquired Company||Date||Deal Size|
|OnTrack Diabetes||September 26, 2013|
|WellApps||March 07, 2012|
Prognos has 733 Twitter Followers. The number of followers has increased 2.3% month over month and increased 5.3% quarter over quarter
Tweets last 30 days
Avg. likes per Tweet
Tweets with engagement
When was Prognos founded?
Prognos was founded in 2010.
Who are Prognos key executives?
Prognos's key executives are Sundeep Bhan, Jason Bhan and Steve Chase.
How many employees does Prognos have?
Prognos has 87 employees.
Who are Prognos competitors?
Competitors of Prognos include Qventus, Examinetics and OM1.
Where is Prognos headquarters?
Prognos headquarters is located at 85 Broad St, New York.
Where are Prognos offices?
Prognos has an office in New York.
How many offices does Prognos have?
Prognos has 1 office.